Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Hot peppers sent him to the ER. Two years later, a ‘ghost bill’ arrived. - 2'Stranger Things' made him a heartthrob. He left Hollywood anyway.
- 35 State of the art Advancements in Computer generated Simulation
- 4ISS astronaut snaps stunning nighttime photo of Florida and Cuba | Space photo of the day for Dec. 29, 2025
- 5Step by step instructions to Pick A Pre-owned vehicle Stage
- Interstellar comet 3I/ATLAS will fly by Earth Friday. Here are the latest images
- UN torture cm'tee report flags Israel for allegedly mistreating journalists, detainees, ex-MAG
- Sound Propensities: 20 Methods for helping Your Insusceptible Framework
- The most effective method to Arrange a Higher Medical caretaker Pay During Your Next New employee screening
- Hezbollah rockets hit 165 UNIFIL positions in Lebanon while targeting Israel, IDF reveals
- Top Frozen yogurt Flavor: Cast Your Vote!
- Why most Jewish Israelis back the death penalty for terrorists
- Charli xcx teases new film ‘The Moment’: What to know about the A24 movie
- 7 Moves toward a Sound and Dynamic Way of life
